Delivery Order SPE2DB20D3103-SPE2DB25FP7X8
- Not listed
- The Defense Logistics Agency awarded a $1,076.62 firm fixed price delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL, with an ultimate completion date of September 12, 2025. This non-set-aside contract represents a single delivery order fulfilling pharmaceutical supply needs for federal medical procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the Defense Logistics Agency's Medical Supply Chain...
- The Defense Logistics Agency awarded a Delivery Order valued at $1,019.16 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL on April 22, 2025, with an ultimate completion date of April 23, 2025. This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,569.66 for Testosterone Cypionate 200 mg/mL on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of pharmaceutical supply services to support federal medical procurement needs. The contract was not issued under any set-aside program and will be performed at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $1,416 delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order, awarded September 12, 2025, represents a non-competitive set-aside transaction and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $1,786.65 delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price contract, issued without set-aside designation, represents a competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026. The place of...
- The Defense Logistics Agency awarded a $1,925.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL on April 22, 2025, with completion targeted for April 23, 2025. This is a competitively awarded, non-set-aside contract with performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a delivery order valued at $1,743.48 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/ml. This non-set-aside, competitively awarded contract carries a firm fixed price structure and is scheduled for completion by August 27, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,679.78 by the Defense Logistics Agency (DLA) on September 19, 2025, for the supply of Testosterone Cypionate 200 mg/mL. The contract is not set-aside and employs firm fixed-price pricing with an ultimate completion date of September 22, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $3,460.46 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL, with an ultimate completion date of June 17, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance, which is also the location of AmerisourceBergen's corporate headquarters. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,528.26 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP7X8Delivery Order
The Defense Logistics Agency awarded a $3,040.02 delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL on August 8, 2025, with an ultimate completion date of August 11, 2025. This is a competitively awarded, firm fixed price contract with no set-aside designation. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support Medical, a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to meet diverse pharmaceutical supply requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. The DLA's planned Pharmaceutical Prime Vendor Global Program Generation V initiative intends to establish multiple regional contracts with at least three different contractors, positioning AmerisourceBergen to continue serving customers including the Defense Health Agency and U.S. Coast Guard through flexible contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 8/8/25 |